Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Air Mancur Prolinu
- Development stage
- Unknown
- Lead developer
- Combiphar
- Administration
- Oral
01
Overview
Air Mancur Prolinu is an approved traditional herbal supplement (jamu) developed by Air Mancur, a subsidiary of Combiphar. It is formulated as a capsule containing a mixture of natural plant extracts, including temulawak (Curcuma xanthorrhiza), lengkuas (Languas galanga), lempuyang wangi (Zingiber aromaticum), alang-alang (Imperata cylindrica), bangle (Zingiber purpureum), bunga sekam (Achyranthes aspera), ketumbar (Coriandrum sativum), cabai jawa (Piper retrofractum), jinten hitam (Nigella sativa), and lada hitam (Piper nigrum). Prolinu is indicated to help relieve muscle pain, stiffness, and fatigue (pegal linu) while refreshing the body.
- Brand names
- Air Mancur ProlinuProlinu
- Other names
- Air Mancur Prolinu KapsulProlinu Kapsul
Beyond the preview
Go deeper on Air Mancur Prolinu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Air Mancur Prolinu.